RNS9 Nov 2022 12:44
Read the recent RNS few times and to me its appears, Immu could be in preparation of Phase 2 trail with FDA recommendation. Question - who is gaining to pay for the trail and wait 6-8 months for results and another FDS approval? Avion?
In summary, the FDA response earlier this month, recommended assessing the potential to use higher dosing in the next clinical program of Lupuzor™ in Lupus, to optimise the clinical benefit to Lupus patients and to maximise efficacy. In addition, the FDA made additional recommendations on clinical measurements, again to support Lupuzor™ through the regulatory process to approval.